BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34445562)

  • 1. Interaction between SCP3 and JAB1 Confers Cancer Therapeutic Resistance and Stem-like Properties through EGF Expression.
    Oh SJ; Noh KH; Song KH; Kim TW
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
    Wang J; Barnes RO; West NR; Olson M; Chu JE; Watson PH
    Breast Cancer Res; 2008; 10(3):R51. PubMed ID: 18534028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Approach to Unraveling the Apoptotic Potential of Rutin (Bioflavonoid) via Targeting
    Pandey P; Khan F; Alzahrani FA; Qari HA; Oves M
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
    Nam AR; Kim JW; Park JE; Bang JH; Jin MH; Oh DY; Bang YJ
    Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
    Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX
    Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptonemal complex protein 3 is a prognostic marker in cervical cancer.
    Cho H; Noh KH; Chung JY; Takikita M; Chung EJ; Kim BW; Hewitt SM; Kim TW; Kim JH
    PLoS One; 2014; 9(6):e98712. PubMed ID: 24905095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
    Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
    J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAB1 regulates CPNE1-related differentiation via direct binding to CPNE1 in HiB5 hippocampal progenitor cells.
    Yoo JC; Park N; Choi HY; Park JY; Yi GS
    Biochem Biophys Res Commun; 2018 Feb; 497(1):424-429. PubMed ID: 29448099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
    Lu Z; Li Y; Che Y; Huang J; Sun S; Mao S; Lei Y; Li N; Sun N; He J
    Cancer Lett; 2018 Sep; 432():156-168. PubMed ID: 29908210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.
    Danielpour D; Purighalla S; Wang E; Zmina PM; Sarkar A; Zhou G
    Biochem Biophys Res Commun; 2019 Oct; 518(2):374-380. PubMed ID: 31434609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of c-Jun activation domain-binding protein-1 in cancer: A systematic review and meta-analysis.
    Shi D; Mu S; Hu B; Zhang S; Liu J; Zhang Z; Shao Z
    J Cell Mol Med; 2021 Mar; 25(6):2750-2763. PubMed ID: 33550701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.
    Clark PA; Iida M; Treisman DM; Kalluri H; Ezhilan S; Zorniak M; Wheeler DL; Kuo JS
    Neoplasia; 2012 May; 14(5):420-8. PubMed ID: 22745588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53.
    Lee EW; Oh W; Song HP; Kim WK
    BMB Rep; 2017 Jul; 50(7):373-378. PubMed ID: 28539160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway.
    Yu S; Wang Y; Lv K; Hou J; Li W; Wang X; Guo H; Wang W
    Technol Cancer Res Treat; 2021; 20():15330338211027916. PubMed ID: 34238066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
    Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
    J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders.
    Yang Y; Song R; Gao Y; Yu H; Wang S
    Mol Med; 2023 Jun; 29(1):80. PubMed ID: 37365502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
    Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
    J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo.
    Samsa WE; Mamidi MK; Bashur LA; Elliott R; Miron A; Chen Y; Lee B; Greenfield EM; Chan R; Danielpour D; Zhou G
    Oncogene; 2020 Jun; 39(23):4581-4591. PubMed ID: 32390003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
    Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
    Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.